Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCHOWW trial of neoadjuvant chemoradiation plus consolidation chemotherapy with or without oxaliplatin for distal rectal cancer
RBR-5j3j9z9Phase 3Not yet recruiting
- Sponsor
- Hospital Alemão Oswaldo Cruz
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of capecitabine, oxaliplatin, fluorouracil and folinic acid in rectal adenocarcinoma and rectal cancer (2 arms), sponsored by Hospital Alemão Oswaldo Cruz. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
capecitabineoxaliplatinfluorouracilfolinic acid
03
Conditions
rectal adenocarcinomarectal cancer
Beyond the preview
Go deeper on RBR-5j3j9z9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5j3j9z9.